322 related articles for article (PubMed ID: 20833510)
1. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes.
Lee TP; Tang SJ; Wu MF; Song YC; Yu CL; Sun KH
J Autoimmun; 2010 Dec; 35(4):358-67. PubMed ID: 20833510
[TBL] [Abstract][Full Text] [Related]
2. Interactions of surface-expressed TLR-4 and endosomal TLR-9 accelerate lupus progression in anti-dsDNA antibody transgenic mice.
Lee TP; Huang JC; Liu CJ; Chen HJ; Chen YH; Tsai YT; Yang W; Sun KH
Exp Biol Med (Maywood); 2014 Jun; 239(6):715-23. PubMed ID: 24719374
[TBL] [Abstract][Full Text] [Related]
3. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
5. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
[TBL] [Abstract][Full Text] [Related]
6. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis.
Sun KH; Yu CL; Tang SJ; Sun GH
Immunology; 2000 Mar; 99(3):352-60. PubMed ID: 10712664
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
10. Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies.
Spatz L; Iliev A; Saenko V; Jones L; Irigoyen M; Manheimer-Lory A; Gaynor B; Putterman C; Bynoe M; Kowal C; Kuo P; Newman J; Diamond B
Methods; 1997 Jan; 11(1):70-8. PubMed ID: 8990091
[TBL] [Abstract][Full Text] [Related]
11. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
[TBL] [Abstract][Full Text] [Related]
12. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
13. Blockade of TLR9 signaling in B cells impaired anti-dsDNA antibody production in mice induced by activated syngenic lymphocyte-derived DNA immunization.
Chen M; Zhang W; Xu W; Zhang F; Xiong S
Mol Immunol; 2011 Jul; 48(12-13):1532-9. PubMed ID: 21592581
[TBL] [Abstract][Full Text] [Related]
14. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
Han B; Moore PA; Wu J; Luo H
Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
[TBL] [Abstract][Full Text] [Related]
17. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
[TBL] [Abstract][Full Text] [Related]
18. New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus.
Putterman C
Autoimmun Rev; 2004 Feb; 3(2):7-11. PubMed ID: 15003182
[TBL] [Abstract][Full Text] [Related]
19. Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.
Kumar S; Bunting KA; Kalsi J; Hinks JA; Latchman DS; Pearl LH; Isenberg DA
Immunology; 2005 Mar; 114(3):418-27. PubMed ID: 15720443
[TBL] [Abstract][Full Text] [Related]
20. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
